Regulatory Alerts2020-01-01 | Bulletin 2020-12Oregon Division of Financial Regulation Bulletin 2020-12: 60-Day Advance Notice Requirements for Prescription Drug Price Increases Under HB 2658
The Oregon Division of Financial Regulation issued Bulletin 2020-12 to implement reporting requirements under 2019 House Bill 2658, mandating pharmaceutical manufacturers to submit 60-day advance notices for specified prescription drug price increases. Manufacturers must report cumulative price hikes meeting defined thresholds, specifically 10 percent or $10,000 for brand-name drugs and both 25 percent and $300 for generics, calculated against Wholesale Acquisition Cost within a rolling 12-month period beginning after June 30, 2020. These reports will be publicly posted on the division website unless manufacturers successfully claim trade secret exemptions, and they are explicitly exempt from the fee structure established by the separate 2018 House Bill 4005.